Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Ramipril
Drug ID BADD_D01909
Description Ramipril is a prodrug belonging to the angiotensin-converting enzyme (ACE) inhibitor class of medications. It is metabolized to ramiprilat in the liver and, to a lesser extent, kidneys. Ramiprilat is a potent, competitive inhibitor of ACE, the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Ramipril may be used in the treatment of hypertension, congestive heart failure, nephropathy, and to reduce the rate of death, myocardial infarction and stroke in individuals at high risk of cardiovascular events.
Indications and Usage For the management of mild to severe hypertension. May be used to reduce cardiovascular mortality following myocardial infarction in hemodynamically stable individuals who develop clinical signs of congestive heart failure within a few days following myocardial infarction. To reduce the rate of death, myocardial infarction and stroke in individuals at high risk of cardiovascular events. May be used to slow the progression of renal disease in individuals with hypertension, diabetes mellitus and microalubinuria or overt nephropathy.
Marketing Status Prescription; Discontinued
ATC Code C09AA05
DrugBank ID DB00178
KEGG ID D00421
MeSH ID D017257
PubChem ID 5362129
TTD Drug ID D01STB
NDC Product Code 50090-5947; 68001-430; 82348-101; 70518-3038; 65862-477; 68382-146; 68382-147; 62135-272; 61570-112; 65841-699; 15308-0300; 61919-157; 76282-673; 57237-223; 63187-277; 68382-144; 71205-029; 0054-0106; 51655-346; 57237-222; 68001-428; 55111-438; 71335-1057; 65862-476; 69037-0051; 65862-320; 63187-854; 76282-671; 0054-0109; 68382-375; 68382-374; 51655-347; 51655-144; 71205-080; 0054-0107; 65862-474; 65862-475; 16729-152; 45865-443; 50090-3059; 55111-440; 63187-644; 17404-1021; 45865-441; 65841-655; 68001-431; 57237-224; 57237-225; 68180-590; 61570-110; 71335-1056; 50090-1118; 60760-481; 0054-0108; 63187-073; 60760-571; 50090-5673; 68001-429; 53104-7573; 71335-0894; 63629-1254; 65841-701; 68382-377; 62135-274; 61570-120; 68382-145; 55111-439; 63187-915; 63187-816; 50090-5730; 68180-591; 50090-4597; 62135-273; 16729-155; 61570-111; 65841-657; 68554-0004; 50090-4691; 65841-658; 12854-207; 16729-153; 68382-376; 65841-702; 16729-154; 55111-441; 62135-271; 65841-656; 60760-477; 76282-672; 76282-670; 50090-3873; 61919-179; 65841-700; 70518-1200; 55111-057; 63187-503; 60760-476; 58032-0123; 55700-551; 68180-589
Synonyms Ramipril | Vesdil | Triatec | Altace | Zabien | Ramace | Tritace | Acovil | Delix | Carasel | HOE-498 | HOE 498 | HOE498
Chemical Information
Molecular Formula C23H32N2O5
CAS Registry Number 87333-19-5
SMILES CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Blood pressure decreasedAngiotensin-converting enzymeP12821T8257716395257; 16138565; 9270093; 10535720; 9726242; 10620209; 10880412; 8986921; 10999650
CoughB2 bradykinin receptorP30411T2371410904024; 12522467; 11699055; 15894833
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Epistaxis24.07.01.005; 22.04.03.0010.002998%
Eructation07.01.02.0030.000600%
Erysipelas23.09.01.002; 11.02.06.0010.000400%Not Available
Erythema23.03.06.0010.006795%Not Available
Erythema multiforme23.03.01.003; 10.01.03.015--
Extrasystoles02.03.02.0030.001199%Not Available
Eye swelling06.08.03.0030.001399%Not Available
Eyelid oedema23.04.01.003; 10.01.05.001; 06.04.04.0040.000600%Not Available
Face oedema10.01.05.002; 23.04.01.004; 08.01.07.0030.001599%
Facial pain08.01.08.0120.000400%
Fallot's tetralogy03.07.06.001; 02.08.01.0020.000799%Not Available
Fatigue08.01.01.002--
Feeling abnormal08.01.09.0140.003398%Not Available
Feeling drunk08.01.09.0150.000999%Not Available
Feeling hot08.01.09.0090.001599%Not Available
Feelings of worthlessness19.15.02.0080.000400%Not Available
Flatulence07.01.04.0020.001199%
Flushing23.06.05.003; 08.01.03.025; 24.03.01.002--
Food interaction08.06.03.0020.000999%Not Available
Formication19.10.02.010; 17.02.06.0180.001199%Not Available
Gait disturbance17.02.05.016; 08.01.02.002--
Gallbladder disorder09.03.02.0010.000999%Not Available
Gamma-glutamyltransferase increased13.03.01.0110.001399%
Gastritis07.08.02.0010.000400%
Gastritis erosive07.04.03.0030.000799%Not Available
Gastrooesophageal reflux disease07.02.02.0030.001599%
Gastroenteritis11.01.07.004; 07.19.03.0010.000600%Not Available
Gastrointestinal disorder07.11.01.001--Not Available
Gastrointestinal pain07.01.05.005--
Generalised oedema14.05.06.007; 08.01.07.0040.000600%
The 7th Page    First    Pre   7 8 9 10 11    Next   Last    Total 24 Pages